The prevalence of hyperinsulinemia is quite high in the overall cohort (13.0%–46.2%), demonstrating the importance of screening for insulin response during a glucose challenge in a population presenting for PCOS and androgen excess. The gene discussed is INS; the disease is polycystic ovary syndrome.